Rajesh K. Malik

2020

In 2020, Rajesh K. Malik earned a total compensation of $1.4M as Chief Medical Officer at G1 Therapeutics, a 2% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$148,750
Option Awards$836,733
Salary$424,000
Other$8,550
Total$1,418,033

Malik received $836.7K in option awards, accounting for 59% of the total pay in 2020.

Malik also received $148.8K in non-equity incentive plan, $424K in salary and $8.6K in other compensation.

Rankings

In 2020, Rajesh K. Malik's compensation ranked 7,094th out of 13,090 executives tracked by ExecPay. In other words, Malik earned more than 45.8% of executives.

ClassificationRankingPercentile
All
7,094
out of 13,090
46th
Division
Manufacturing
2,961
out of 5,621
47th
Major group
Chemicals And Allied Products
1,195
out of 2,254
47th
Industry group
Drugs
1,028
out of 1,954
47th
Industry
Pharmaceutical Preparations
767
out of 1,459
47th
Source: SEC filing on April 28, 2021.

Malik's colleagues

We found five more compensation records of executives who worked with Rajesh K. Malik at G1 Therapeutics in 2020.

2020

Mark Velleca

G1 Therapeutics

Chief Executive Officer

2020

Soma Gupta

G1 Therapeutics

Chief Commercial Officer

2020

Jennifer Moses

G1 Therapeutics

Chief Financial Officer

2020

Mark Avagliano

G1 Therapeutics

Chief Business Officer

2020

John Bailey

G1 Therapeutics

Chief Executive Officer

News

In-depth

You may also like